Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Loula Papageorgiou, Patrick Van Dreden, PhD, Laurent Garderet, MD PhD, Matthieu Grusse, Ismail Elalamy, MD PhD, Grigoris Gerotziafas, MD PhD

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-139424

Published: 2020

Journal Articles

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study

Patrick Van Dreden, PhD, Guillaume Voiriot, Alexandre Alabbadi, Ismail Elalamy, MD PhD, Loula Papageorgiou, Hélène Cost, Aurélie Rousseau, PhD, Matthieu Turpin, Muriel Fartoukh, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-140275

Published: 2020

Journal Articles

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Grigoris Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Loula Papageorgiou, Theodoros N Sergentanis, MD PhD, Meletios-Athanasios Dimopoulos, Ismail Elalamy, MD PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-136528

Published: 2020

Journal Articles

Analysis of the Safety Profiles of Anticoagulants Using the EMA Pharmacovigilance Database

Ismail Elalamy, MD PhD

Blood (2019) 134 (Supplement_1): 4979.

https://doi.org/10.1182/blood-2019-123031

Published: 2019

Journal Articles

Procoagulant Microparticles Derived from Myeloma Plasma Cells Have a Determinant Role in the Hypercoagulable State Associated with Multiple Myeloma. a Modelization in Vitro Study

Loula Papageorgiou, Patrick Van Dreden, PhD, Meletios A. Dimopoulos, MD, Annette Larsen, Mohamad Mohty, MD PhD, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas

Blood (2019) 134 (Supplement_1): 2425.

https://doi.org/10.1182/blood-2019-124650

Published: 2019

Journal Articles

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Loula Papageorgiou, Despina Fotiou, BMBS, MA, Patrick Van Dreden, PhD, Laurent Garderet, MD PhD, Meletios A. Dimopoulos, MD, Ismail Elalamy, MD PhD, Mohamad Mohty, MD PhD, Grigoris Gerotziafas, MD PhD

Blood (2019) 134 (Supplement_1): 1913.

https://doi.org/10.1182/blood-2019-126954

Published: 2019

Journal Articles

Pathogenic Heparin Induced Thrombocytopenia and Thrombosis (HIT) Antibodies Determined By Simple Rapid Functional Flow Cytometry

Varda R Deutsch, PhD, Michal Cipok, PhD, Ilya Kirgner, MD, Sigi Kay, PhD, Ismail Elalamy, MD PhD, Aaron Tomer, MD

Blood (2018) 132 (Supplement 1): 3801.

https://doi.org/10.1182/blood-2018-99-118296

Published: 2018

Journal Articles

In Newly Diagnosed Multiple Myeloma Patients, Longer Procoagulant Phospholipid-Dependent Clotting Time, Higher Levels of P-Selectin, D-Dimers and Thrombin Generation Peak Are Associated with Increased Risk of Resistance to Treatment: Results of the Prospective Roadmap-MM Study

Grigorios T. Gerotziafas, Despina Fotiou, BMBS, MA, Patrick Van Dreden, PhD, Theodoros N Sergentanis, Ismail Elalamy, MD PhD, Loula Papageorgiou, Matthieu Grusse, Stella Salta, Theodora Psaltopoulou, Annette Larsen, Evangelos Terpos, MD PhD, Meletios A Dimopoulos, MD

Blood (2018) 132 (Supplement 1): 2014.

https://doi.org/10.1182/blood-2018-99-114871

Published: 2018

Journal Articles

Defining the Balance between the Expression of Procoagulant, Anticoagulant and Angiogenic Molecules in Myeloma Plasma Cells

Loula Papageorgiou, Sandrine Thouronde, Patrick Van Dreden, PhD, Stella Salta, Laurent Garderet, MD PhD, Christelle Mazurier, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 5364.

https://doi.org/10.1182/blood.V130.Suppl_1.5364.5364

Published: 2017

Journal Articles

Procoagulant Phospholipid Dependent Clotting Time: A New Tool for the Identification of Multiple Myeloma Patients at Risk Poor Treatment Response

Fotiou Despina, Loula Papageorgiou, Stella Salta, Patrick Van Dreden, PhD, Evangelos Terpos, Jawed Fareed, PhD, Matthieu Grusse, Ismail Elalamy, MD PhD, Laurent Garderet, MD PhD, Christelle Mazurier, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 1110.

https://doi.org/10.1182/blood.V130.Suppl_1.1110.1110

Published: 2017

Journal Articles

An Ex Vivo Analysis of Thrombin Generation and Thromboelastometry in Patients Undergoing Treatment with Rivaroxaban Demonstrates Sustained Anticoagulant Effect and High Inter-Individual Variability

Stella Salta, Patrick Van Dreden, PhD, Loula Papageorgiou, Jawed Fareed, PhD, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 3722.

https://doi.org/10.1182/blood.V130.Suppl_1.3722.3722

Published: 2017

Journal Articles

Alteration of Endothelial Cell Hemostatic Equilibrium By Cancer Cell-Derived Microparticles, a New Insight in Pathogenesis of Cancer Associated Thrombosis

Aurélie Rousseau, PhD, Rania Amrane, Patrick Van Dreden, PhD, Loula Papageorgiou, Annette Larsen, Amir Khaterchi, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 3698.

https://doi.org/10.1182/blood.V130.Suppl_1.3698.3698

Published: 2017

Journal Articles

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study

Grigorios T. Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Stella Salta, Loula Papageorgiou, Paraskevi Boura, Annette Larsen, Jawed Fareed, PhD, Konstantinos Syrigos, Ismail Elalamy, MD PhD

Blood (2017) 130 (Supplement 1): 2381.

https://doi.org/10.1182/blood.V130.Suppl_1.2381.2381

Published: 2017

Journal Articles

Sensitive and Specific Functional Flow Cytometry Assay for Rapid Diagnosis of Heparin Induced Thrombocytopenia and Thrombosis (HIT)

Michal Cipok, PhD, Aaron Tomer, MD, Ismail Elalamy, MD PhD, Ilya Kirgner, MD, Naama Dror, PhD, Sigi Kay, PhD, Varda R Deutsch, PhD

Blood (2017) 130 (Supplement 1): 2341.

https://doi.org/10.1182/blood.V130.Suppl_1.2341.2341

Published: 2017

Journal Articles

Easily Performed Functional Flow Cytometry Assay for Heparin-Induced Thrombocytopenia and Thrombosis (HIT): Correlation with Clinical Presentation, Immunoassay and Serotonin-Release Assay

Michal Cipok, PhD, Varda R Deutsch, PhD, Ismail Elalamy, MD PhD, Ilya Kirgner, MD, Sigi Kay, PhD, Aaron Tomer, MD

Blood (2016) 128 (22): 2601.

https://doi.org/10.1182/blood.V128.22.2601.2601

Published: 2016

Journal Articles

Idarucizumab, a Specific Antidote for Dabigatran, Cross-Reacts with Melagatran and May Also Interact with Other Benzamidine-Containing Compounds

Jawed Fareed, PhD, Larissa Reikensmeyer, Amanda Walborn, BS, Debra Hoppensteadt, PhD, Jeanine M. Walenga, PhD, Eduardo Ramacciotti, MD, Schuharazad Abro, MD, Walter Jeske, PhD, Olivia Bouchard, Ismail Elalamy, MD PhD

Blood (2016) 128 (22): 3836.

https://doi.org/10.1182/blood.V128.22.3836.3836

Published: 2016

Journal Articles

Comparison of Ufh and Enoxaparin Originated from Bovine, Ovine and Porcine Mucosa with Functional Coagulation Assays

Grigorios T. Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Walter Jeske, PhD, Jeanine M. Walenga, PhD, Debra Hoppensteadt, PhD, Annette Larsen, Ismail Elalamy, MD PhD, Yiming Yao, Jawed Fareed, PhD

Blood (2016) 128 (22): 5020.

https://doi.org/10.1182/blood.V128.22.5020.5020

Published: 2016

Journal Articles

Endothelial Cell Markers Kinetics Following Umbilical Cord Blood Transplantation in Adults.

Anna D. Petropoulou, MD, Ismail Elalamy, MD, PhD, Jeannette Soria, PhD, Pezhman Mirshahi, PhD, Francine Rendu, PhD, Michel Meyer Samama, Jean Pierre Marie, Bernard Rio, MD

Blood (2007) 110 (11): 4964.

https://doi.org/10.1182/blood.V110.11.4964.4964

Published: 2007

Journal Articles

Differential Procoagulant Phenotype of Pancreatic and Breast Cancer Cells Related to Different Tissue Factor Activity.

Grigoris T. Gerotziafas, MD, PhD, Ismail Elalamy, MD PhD, Marie-Paule Roman, Claudine Prengel, Elisabeth Verdy, MD PhD, Jean-François Bernaudin

Blood (2007) 110 (11): 3992.

https://doi.org/10.1182/blood.V110.11.3992.3992

Published: 2007

Journal Articles

Platelets and Heparin Induced Thrombocytopenia Antibodies Do Not Influence the Inhibitory Activity of Argatroban on Thrombin Generation.

Grigoris T. Gerotziafas, MD, PhD, Marie-Paule Roman, Elisabeth Verdy, MD, PhD, Mohamed Hatmi, PhD, Meyer M. Samama, Ismail Elalamy, MD, PhD

Blood (2007) 110 (11): 929.

https://doi.org/10.1182/blood.V110.11.929.929

Published: 2007

NARROW

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Analysis of the Safety Profiles of Anticoagulants Using the EMA Pharmacovigilance Database

Procoagulant Microparticles Derived from Myeloma Plasma Cells Have a Determinant Role in the Hypercoagulable State Associated with Multiple Myeloma. a Modelization in Vitro Study

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Pathogenic Heparin Induced Thrombocytopenia and Thrombosis (HIT) Antibodies Determined By Simple Rapid Functional Flow Cytometry

In Newly Diagnosed Multiple Myeloma Patients, Longer Procoagulant Phospholipid-Dependent Clotting Time, Higher Levels of P-Selectin, D-Dimers and Thrombin Generation Peak Are Associated with Increased Risk of Resistance to Treatment: Results of the Prospective Roadmap-MM Study

Defining the Balance between the Expression of Procoagulant, Anticoagulant and Angiogenic Molecules in Myeloma Plasma Cells

Procoagulant Phospholipid Dependent Clotting Time: A New Tool for the Identification of Multiple Myeloma Patients at Risk Poor Treatment Response

An Ex Vivo Analysis of Thrombin Generation and Thromboelastometry in Patients Undergoing Treatment with Rivaroxaban Demonstrates Sustained Anticoagulant Effect and High Inter-Individual Variability

Alteration of Endothelial Cell Hemostatic Equilibrium By Cancer Cell-Derived Microparticles, a New Insight in Pathogenesis of Cancer Associated Thrombosis

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study

Sensitive and Specific Functional Flow Cytometry Assay for Rapid Diagnosis of Heparin Induced Thrombocytopenia and Thrombosis (HIT)

Easily Performed Functional Flow Cytometry Assay for Heparin-Induced Thrombocytopenia and Thrombosis (HIT): Correlation with Clinical Presentation, Immunoassay and Serotonin-Release Assay

Idarucizumab, a Specific Antidote for Dabigatran, Cross-Reacts with Melagatran and May Also Interact with Other Benzamidine-Containing Compounds

Comparison of Ufh and Enoxaparin Originated from Bovine, Ovine and Porcine Mucosa with Functional Coagulation Assays

Endothelial Cell Markers Kinetics Following Umbilical Cord Blood Transplantation in Adults.

Differential Procoagulant Phenotype of Pancreatic and Breast Cancer Cells Related to Different Tissue Factor Activity.

Platelets and Heparin Induced Thrombocytopenia Antibodies Do Not Influence the Inhibitory Activity of Argatroban on Thrombin Generation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only